Search Results - "Mazepa, Marshall A"

How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns by Mazepa, Marshall A., Masias, Camila, Chaturvedi, Shruti

“…Insights into immune-mediated thrombotic thrombocytopenic purpura (iTTP) pathophysiology have led to novel targeted therapies. Immunomodulatory strategies…”
Get full text

Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura by Mazepa, Marshall A., Raval, Jay S., Moll, Stephan, Ma, Alice, Park, Yara A.

Get full text

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B by Soucie, J. Michael, Monahan, Paul E., Kulkarni, Roshni, Konkle, Barbara A., Mazepa, Marshall A.

“…Data are needed on minimal factor activity (FA) levels required to prevent bleeding in hemophilia. We aimed to evaluate associations between hemophilia type…”
Get full text

Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange by Peedin, Alexis R, Park, Yara A, Mazepa, Marshall A, Rollins‐Raval, Marian A, Brecher, Mark E, Raval, Jay S

“…Acquired thrombotic thrombocytopenic purpura (TTP) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and commonly ADAMTS13 deficiency…”
Get full text

The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical students by Peedin, Alexis R, Perjar, Irina, Mazepa, Marshall A, Rollins-Raval, Marian A, Park, Yara A, Raval, Jay S

“…Transfusion medicine (TM) knowledge varies widely among physician trainees. In addition, there have been few instances in which curricular changes have been…”
Get full text

Men with severe hemophilia in the United States: birth cohort analysis of a large national database by Mazepa, Marshall A., Monahan, Paul E., Baker, Judith R., Riske, Brenda K., Soucie, J.Michael

“…The availability of longitudinal data collected prospectively from 1998 to 2011 at federally funded US hemophilia treatment centers provided an opportunity to…”
Get full text

Cardiovascular Disease and Stroke in Immune TTP-Challenges and Opportunities by Sukumar, Senthil, Mazepa, Marshall A, Chaturvedi, Shruti

“…Advances in the management of immune thrombotic thrombocytopenic purpura (iTTP) have dramatically improved outcomes of acute TTP episodes, and TTP is now…”
Get full text

Race, rituximab, and relapse in TTP by Chaturvedi, Shruti, Antun, Ana G, Farland, Andrew M, Woods, Ryan, Metjian, Ara, Park, Yara A, de Ridder, Gustaaf, Gibson, Briana, Kasthuri, Raj S, Liles, Darla K, Akwaa, Frank, Clover, Todd, Baumann Kreuziger, Lisa, Sadler, J Evan, Sridharan, Meera, Go, Ronald S, McCrae, Keith R, Upreti, Harsh Vardhan, Liu, Angela, Lim, Ming Y, Gangaraju, Radhika, Zheng, X Long, Raval, Jay S, Masias, Camila, Cataland, Spero R, Johnson, Andrew, Davis, Elizabeth, Evans, Michael D, Mazepa, Marshall A

“…Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring episodes of thrombotic microangiopathy, causing ischemic organ…”
Get full text

Major adverse cardiovascular events in survivors of immune‐mediated thrombotic thrombocytopenic purpura by Brodsky, Max A., Sukumar, Senthil, Selvakumar, Sruthi, Yanek, Lisa, Hussain, Sarah, Mazepa, Marshall A., Braunstein, Evan M., Moliterno, Alison R., Kickler, Thomas S., Brodsky, Robert A., Cataland, Spero R., Chaturvedi, Shruti

“…Cardiovascular disease is a leading cause of death in survivors of immune‐mediated thrombotic thrombocytopenic purpura (iTTP), but the epidemiology of major…”
Get full text

Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura by Brown, Jenna, Potugari, Bindu, Mazepa, Marshall A., Kohli, Ruhail, Moliterno, Alison R., Brodsky, Robert A., Vaught, Jason A., Burwick, Richard, Chaturvedi, Shruti

“…Pregnancy is a well-established trigger for a first episode or relapse of immune thrombotic thrombocytopenic purpura (iTTP). Other outcomes of subsequent…”
Get full text

Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients by Raval, Jay S., Mazepa, Marshall A., Rollins‐Raval, Marian A., Kasthuri, Raj S., Park, Yara A.

“…BACKGROUND Despite rapid and intensive treatments with therapeutic plasma exchange (TPE) and immunosuppression, immune thrombotic thrombocytopenic purpura…”
Get full text

Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies by Mazepa, Marshall A, Park, Yara A, Raval, Jay S

“…Immune thrombotic thrombocytopenic purpura (iTTP) is a chronically relapsing, humorally-mediated autoimmune disorder characterized by unpredictable episodes of…”
Get full text

Opioid exposure in haemophilia patients is common and underreported by Peltier, Skye J., Mazepa, Marshall A., Freese, Rebecca L., Nelson, Shannon F., Kearney, Susan L., Reding, Mark T.

“…Introduction In an era of increased opioid awareness, data on opioid exposure in haemophilia patients are lacking. Aim The objectives of this study were to (a)…”
Get full text

The Impact of an Undergraduate Biology Class on Donor Recruitment at a Hospital-Based Blood Donor Center by Peedin, Alexis R, Park, Yara A, Mazepa, Marshall A, Siniard, R Chad, Neish, Thomas, Raval, Jay S

“…Abstract Objectives A biology class, BIOL 294H, taught undergraduates about platelet donation while partnering with the University of North Carolina’s (UNC’s)…”
Get full text

Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoise by Mazepa, Marshall A., Raval, Jay S., Brecher, Mark E., Park, Yara A.

“…Background The purpose of this survey was to describe current practices in the U.S. for treatment of acquired Thrombotic Thrombocytopenic Purpura (TTP),…”
Get full text

How we approach an acquired thrombotic thrombocytopenic purpura patient by Raval, Jay S., Mazepa, Marshall A., Brecher, Mark E., Park, Yara A.

“…Acquired thrombotic thrombocytopenic purpura (TTP) is a disease characterized by microangiopathic hemolytic anemia and thrombocytopenia, in addition to…”
Get full text

Heterogeneity of diagnosis, treatment, and management for immune thrombotic thrombocytopenic purpura: Are we still peering through the looking glass? by Raval, Jay S., Rollins‐Raval, Marian A., Mazepa, Marshall A., Park, Yara A.

Get full text

Pathology consultation on electronic crossmatch by Mazepa, Marshall A, Raval, Jay S, Park, Yara A

“…The full crossmatch is traditionally the final step in compatibility testing, acting as a serologic double check for ABO compatibility and unexpected RBC…”
Get full text

Heparin‐induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis by Raval, Jay S., Park, Yara A., Perjar, Irina, Mazepa, Marshall A., Vincent, Benjamin G., Ma, Alice D., Rollins‐Raval, Marian A.

“…Heparin‐induced thrombocytopenia (HIT) can occur following exposure to heparin and is characterized by thrombocytopenia with increased risk for thrombosis…”
Get full text

Monitoring therapeutic apheresis utilization: Database versus registry by Raval, Jay S., Mazepa, Marshall A., Whinna, Herbert C., Park, Yara A.

Get full text